Sort
53,477 grants matching “addiction”
Person-centered quality measurement and management in a system for addictions treatment in New York State
$2,197,659Charles J Neighbors · New York University School Of Medicine · RM1 · FY2025 · DA
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,196,361Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2019 · DA
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain
$2,195,014James Jeffrey Sahn · 4e Therapeutics Inc. · U44 · FY2023 · NS
Center on Antisocial Drug Dependence: The Genetics of HIV Risk Behaviors
$2,193,298John K Hewitt · University Of Colorado · P60 · FY2012 · DA
Community Clinical Oncology Program
$2,191,843Mayo Clinic Coll Of Medicine, Rochester · U10 · FY2002 · CA
SPORE in Prostate Cancer
$2,190,123Samuel R Denmeade · Johns Hopkins University · P50 · FY2024 · CA
Biology of Neuroendocrine Peptides
$2,190,049Wylie W. Vale · Salk Institute For Biological Studies · P01 · FY2010 · DK
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
$2,189,974Stephen S Hecht · University Of Minnesota · P01 · FY2023 · CA
Neuroimaging Analysis Center (NAC)
$2,186,139Ron Kikinis · Brigham And Women'S Hospital · P41 · FY2014 · EB
The Injectrode - A Truly Injectable Electrode for Dorsal Root Ganglion Stimulation to Treat Pain
$2,185,033Kip A Ludwig · University Of Wisconsin-Madison · U18 · FY2019 · EB
Characterization of neuronal ensembles activated during cue-induced reward seeking
$2,184,496Bruce Hope · National Institute On Drug Abuse · ZIA · FY2021 · DA
ICAL: Impact of Cannabinoids Across Lifespan
$2,184,221Daniele Piomelli · University Of California-Irvine · P50 · FY2021 · DA
Development of Next-generation Pharmacotherapy for Opioid Use Disorders
$2,183,507Nurulain T Zaveri · Astraea Therapeutics, Llc · UH3 · FY2023 · DA
Mirtazapine for methamphetamine use disorder: drug-drug interaction study
$2,182,386Phillip O Coffin · Public Health Foundation Enterprises · U01 · FY2021 · DA
Preclinical and clinical evaluation of the NMDA modulator NYX-783 for OUD
$2,182,107Ralph J Dileone · Yale University · UG3 · FY2019 · DA
ICAL: Impact of Cannabinoids Across Lifespan
$2,181,939Daniele Piomelli · University Of California-Irvine · P50 · FY2020 · DA
Center for Systems Neurogenetics of Addiction
$2,181,681Elissa J Chesler · Jackson Laboratory · P50 · FY2020 · DA
Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN PATHS) study
$2,180,730Emily Ai-Hua Wang · Yale University · UG1 · FY2023 · DA
Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor
$2,180,515Lei Shi · National Institute On Drug Abuse · ZIA · FY2022 · DA
Integrative Omics Center for Accelerating Neurobiological Understanding of Opioid Addiction (ICAN)
$2,179,245Eric O Johnson · Research Triangle Institute · P50 · FY2024 · DA
Integrative Omics Center for Accelerating Neurobiological Understanding of Opioid Addiction (ICAN)
$2,175,485Eric O Johnson · Research Triangle Institute · P50 · FY2025 · DA
Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center
$2,172,667Peter D. Friedmann · Baystate Medical Center, Inc. · UG1 · FY2020 · DA
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN
$2,171,410Daniel F Hanley · Johns Hopkins University · U24 · FY2025 · TR
Parents' Translational Research Center
$2,170,866Kimberly C Kirby · Treatment Research Institute · P50 · FY2014 · DA
ICAL: Impact of Cannabinoids Across Lifespan
$2,169,724Daniele Piomelli · University Of California-Irvine · P50 · FY2018 · DA